Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ronald D Alvarez

Showing results (121-130 of 211) with videos related to

Pageof 22
Sort By:
Gynecologic Oncology|October 6, 2009
Fixed-dose rate gemcitabine plus carboplatin in relapsed, platinum-sensitive ovarian cancer patients: results of a three-arm Phase I studyRonald D Alvarez, Robert Mannel, Agustin A García, et al.
International Journal of Cancer|July 15, 2004
Gene transfer to cervical cancer with fiber-modified adenovirusesDaniel T Rein, Martina Breidenbach, Hongju Wu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 30, 2021
GEN-1 in Combination with Neoadjuvant Chemotherapy for Patients with Advanced Epithelial Ovarian Cancer: A Phase I Dose-escalation StudyPremal H Thaker, William H Bradley, Charles A Leath, et al.
Gynecologic Oncology|October 19, 2006
A phase II trial of weekly topotecan for patients with secondary platinum-resistant recurrent epithelial ovarian carcinoma following the failure of second-line therapyWhitney A Spannuth, Charles A Leath, Warner K Huh, et al.
Gynecologic Oncology|June 11, 2011
A cohort study evaluating robotic versus laparotomy surgical outcomes of obese women with endometrial carcinomaAkila Subramaniam, Kenneth H Kim, Shannon A Bryant, et al.
American Journal of Clinical Oncology|December 2, 2016
Safety and Outcome Measures of First-in-Human Intraperitoneal α Radioimmunotherapy With 212Pb-TCMC-TrastuzumabRuby F Meredith, Julien J Torgue, Tania A Rozgaja, et al.
Gynecologic Oncology|May 1, 2016
Improved outcomes with dose-dense paclitaxel-based neoadjuvant chemotherapy in advanced epithelial ovarian carcinomaDavid A Becker, Eric D Thomas, Allison L Gilbert, et al.
Gynecologic Oncology|July 22, 2006
Icodextrin enhances survival in an intraperitoneal ovarian cancer murine model utilizing gene therapyRodney P Rocconi, Michael T Numnum, Zeng B Zhu, et al.
Molecular Pharmacology|August 10, 2006
Circumventing recombination events encountered with production of a clinical-grade adenoviral vector with a double-expression cassetteNatalya Belousova, Raymond Harris, Kurt Zinn, et al.
Gynecologic Oncology|August 12, 2008
A phase I study of lapatinib in combination with carboplatin in women with platinum sensitive recurrent ovarian carcinomaKristopher J Kimball, T Michael Numnum, Tyler O Kirby, et al.
Pageof 22

Showing results (121-130 of 211) with videos related to

Sort By:
Pageof 22
Gynecologic Oncology|October 6, 2009
Fixed-dose rate gemcitabine plus carboplatin in relapsed, platinum-sensitive ovarian cancer patients: results of a three-arm Phase I studyRonald D Alvarez, Robert Mannel, Agustin A García, et al.
International Journal of Cancer|July 15, 2004
Gene transfer to cervical cancer with fiber-modified adenovirusesDaniel T Rein, Martina Breidenbach, Hongju Wu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 30, 2021
GEN-1 in Combination with Neoadjuvant Chemotherapy for Patients with Advanced Epithelial Ovarian Cancer: A Phase I Dose-escalation StudyPremal H Thaker, William H Bradley, Charles A Leath, et al.
Gynecologic Oncology|October 19, 2006
A phase II trial of weekly topotecan for patients with secondary platinum-resistant recurrent epithelial ovarian carcinoma following the failure of second-line therapyWhitney A Spannuth, Charles A Leath, Warner K Huh, et al.
Gynecologic Oncology|June 11, 2011
A cohort study evaluating robotic versus laparotomy surgical outcomes of obese women with endometrial carcinomaAkila Subramaniam, Kenneth H Kim, Shannon A Bryant, et al.
American Journal of Clinical Oncology|December 2, 2016
Safety and Outcome Measures of First-in-Human Intraperitoneal α Radioimmunotherapy With 212Pb-TCMC-TrastuzumabRuby F Meredith, Julien J Torgue, Tania A Rozgaja, et al.
Gynecologic Oncology|May 1, 2016
Improved outcomes with dose-dense paclitaxel-based neoadjuvant chemotherapy in advanced epithelial ovarian carcinomaDavid A Becker, Eric D Thomas, Allison L Gilbert, et al.
Gynecologic Oncology|July 22, 2006
Icodextrin enhances survival in an intraperitoneal ovarian cancer murine model utilizing gene therapyRodney P Rocconi, Michael T Numnum, Zeng B Zhu, et al.
Molecular Pharmacology|August 10, 2006
Circumventing recombination events encountered with production of a clinical-grade adenoviral vector with a double-expression cassetteNatalya Belousova, Raymond Harris, Kurt Zinn, et al.
Gynecologic Oncology|August 12, 2008
A phase I study of lapatinib in combination with carboplatin in women with platinum sensitive recurrent ovarian carcinomaKristopher J Kimball, T Michael Numnum, Tyler O Kirby, et al.
Pageof 22